Variables | Ascites | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Yes (n = 26) | No (n = 120) | P value | OR | 95% CI | P value | |
Age | 70 (31–79, 13) | 69 (33–87, 15) | 0.276 |  |  |  |
Sex (male/female) | 19/7 | 84/36 | 0.755 | Â | Â | Â |
BMI | 21.3 (18.3–26.9, 4.5) | 22.9 (15.4–37.1, 4.5) | 0.162 |  |  |  |
ASA (1 or 2/3) | 20/6 | 104/16 | 0.214 | Â | Â | Â |
Diagnosis (HCC/non-HCC) | 22/4 | 65/55 | 0.007 | 3.442 | 0.751–15.768 | 0.111 |
Background liver condition (hepatitis/normal) | 21/5 | 60/60 | 0.007 | 1.246 | 0.292–5.328 | 0.766 |
Type of resection (major hepatectomya/minor hepatectomyb) | 19/7 | 90/30 | 0.838 | Â | Â | Â |
Number of resected lesions | 1 (1–3, 1) | 1 (1–16, 0) | 0.979 |  |  |  |
Size of the largest nodule on preoperative imagingc (cm) | 2.3 (0.9–20.0, 2.7) | 2.5 (0.5–12.0, 2.0) | 0.582 |  |  |  |
Number of nodules on preoperative imagingc | 1 (1–10, 2) | 1 (1–10, 0) | 0.204 |  |  |  |
Lymph node dissection (yes/no) | 3/23 | 17/103 | 0.724 | Â | Â | Â |
Biliary reconstruction (yes/no) | 1/25 | 10/110 | 0.444 | Â | Â | Â |
Neoadjuvant chemotherapy (yes/no or previous) | 2/24 | 19/101 | 0.295 | Â | Â | Â |
Total bilirubin (mg/dL) (≥ 1.1/ < 1.1) | 8/18 | 25/95 | 0.276 |  |  |  |
Aspartate transaminase (IU/L) (≥ 31/ < 31) | 16/10 | 58/62 | 0.225 |  |  |  |
Albumin (g/dL) (≥ 3.9/ < 3.9) | 13/13 | 81/39 | 0.095 |  |  |  |
Prothrombin activity (%) (≥ 69/ < 69) | 22/4 | 118/2 | 0.008 | 0.275 | 0.032–2.330 | 0.236 |
Activated partial thromboplastin time (%) (≥ 69/ < 69) | 22/4 | 105/15 | 0.692 |  |  |  |
Hemoglobin (g/dL) (≥ 11.4/ < 11.4) | 21/5 | 96/24 | 0.929 |  |  |  |
Platelet (× 104/μL) (≥ 15.3/ < 15.3) | 8/18 | 80/40 | 0.010 | 0.359 | 0.123–1.050 | 0.061 |
Blood urea nitrogen (mg/dL) (≥ 20.0/ < 20.0) | 5/21 | 16/104 | 0.440 |  |  |  |
Creatinine (mg/dL) (≥ 1.07/ < 1.07) | 3/23 | 20/100 | 0.518 |  |  |  |
C-reactive proteind (mg/dL) (≥ 0.14/ < 0.14) | 10/15 | 40/63 | 0.915 |  |  |  |
ICGR15e (%) (≥ 10/ < 10) | 19/7 | 71/43 | 0.588 |  |  |  |
Child–Pugh score | 5 (5–6, 1) | 5 (5–8, 0) | 0.006 | 0.509 | 0.191–1.354 | 0.176 |
Total operative time (min) | 257 (123–673, 167) | 253 (74–670, 115) | 0.397 |  |  |  |
Transection timef (min) | 96 (19–262, 77) | 84 (15–298, 63) | 0.682 |  |  |  |
Pringle maneuverg (min) | 54 (18–158, 51) | 58 (15–159, 31) | 0.962 |  |  |  |
Blood loss (mL) | 565 (35–8030, 997) | 550 (0–5940, 629) | 0.269 |  |  |  |
Red blood cell transfusion (mL) | 0 (0–3360, 90) | 0 (0–2850, 0) | 0.218 |  |  |  |
Hemostatic device (monopolar/bipolar) | 20/6 | 53/67 | 0.004 | 5.626 | 1.881–16.827 | 0.002 |